Pharmaceuticals agents for preventing NSAID-induced gastric ulcers: a patent review

Expert Rev Clin Pharmacol. 2021 Jun;14(6):677-686. doi: 10.1080/17512433.2021.1909475. Epub 2021 Apr 12.

Abstract

Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs widely used due to their pharmacological potential, demonstrating anti-inflammatory, analgesic, or antipyretic activity. However, prolonged use of these medications can lead to the development of gastric ulcers in patients. This review aimed to find patents for drugs with an anti-inflammatory and gastroprotective character to treat NSAID-induced gastric ulcers.

Areas covered: For the treatment of NSAID-induced gastric ulcers, formulations with different action mechanisms were found, including donors of nitric oxide, heterocyclic compounds, and natural products.

Expert opinion: Many of the structures found have already been used in clinic settings and others, and according to the results found, they are promising for the treatment of gastric ulcers.

Keywords: Anti-inflammatory; gastroprotective; intellectual property; nsaids; ulcer gastric.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Ulcer Agents / administration & dosage*
  • Anti-Ulcer Agents / pharmacology
  • Biological Products / administration & dosage
  • Biological Products / pharmacology
  • Heterocyclic Compounds / administration & dosage
  • Heterocyclic Compounds / pharmacology
  • Humans
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Donors / pharmacology
  • Patents as Topic
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / prevention & control*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Biological Products
  • Heterocyclic Compounds
  • Nitric Oxide Donors